HiSpike: A high-throughput cost effective sequencing method for the SARS-CoV-2 spike gene

Ephraim Fass, Gal Zizelski Valenci, Mor Rubinstein, Paul J Freidlin, Shira Rosencwaig, Inna Kutikov, Robert Werner, Nofar Ben-Tovim, Efrat Bucris, Neta S Zuckerman, Orna Mor, Ella Mendelson, Zeev Dveyrin, Efrat Rorman, Israel Nissan
doi: https://doi.org/10.1101/2021.03.02.21252290

Article Information

doi 
https://doi.org/10.1101/2021.03.02.21252290
History 
  • March 5, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Ephraim Fass1,
  2. Gal Zizelski Valenci1,
  3. Mor Rubinstein1,
  4. Paul J Freidlin1,
  5. Shira Rosencwaig1,
  6. Inna Kutikov1,
  7. Robert Werner1,
  8. Nofar Ben-Tovim1,
  9. Efrat Bucris2,
  10. Neta S Zuckerman2,
  11. Orna Mor2,
  12. Ella Mendelson2,
  13. Zeev Dveyrin1,
  14. Efrat Rorman1 and
  15. Israel Nissan1,*
  1. 1National Public Health Laboratory Tel Aviv, Israel Ministry of Health, Israel
  2. 2Central Virology Laboratory, Israel Ministry of Health, Chaim Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel
  1. ↵*Corresponding author: israel.nissan{at}moh.gov.il
Back to top
Posted March 05, 2021.
Download PDF

Supplementary Material

Data/Code
Email
HiSpike: A high-throughput cost effective sequencing method for the SARS-CoV-2 spike gene
Ephraim Fass, Gal Zizelski Valenci, Mor Rubinstein, Paul J Freidlin, Shira Rosencwaig, Inna Kutikov, Robert Werner, Nofar Ben-Tovim, Efrat Bucris, Neta S Zuckerman, Orna Mor, Ella Mendelson, Zeev Dveyrin, Efrat Rorman, Israel Nissan
medRxiv 2021.03.02.21252290; doi: https://doi.org/10.1101/2021.03.02.21252290
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area